Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Janssens

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Neuropharmacology|July 7, 2012
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism studyGeorg Winterer, Jürgen Gallinat, Jürgen Brinkmeyer, et al.
Physiological Reports|October 30, 2025
Pattern of extra-diaphragmatic respiratory muscle activity during exercise in patients with unilateral diaphragm dysfunctionAntenor Rodrigues, Zafeiris Louvaris, Sauwaluk Dacha, et al.
Acta Cardiologica|April 20, 2022
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational studyPhilippe van de Borne, André Peeters, Luc Janssens, et al.
Cardiology Research|August 10, 2023
A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V TrialAlexandre Abizaid, Ricardo Costa, Sasko Kedev, et al.
Journal of the American Heart Association|September 17, 2021
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS TrialPascal Vranckx, Marco Valgimigli, Ayodele Odutayo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
Journal of the American College of Cardiology|October 31, 2024
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA TrialRobert W Yeh, Olivier F Bertrand, Ehtisham Mahmud, et al.
American Heart Journal|January 12, 2020
Validation of the all-comers design: Results of the TARGET-AC substudyGabor G Toth, Alexandra Lansky, Andreas Baumbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
The Journal of Invasive Cardiology|May 23, 2023
iFR/FFR/IVUS Discordance and Clinical Implications: Results From the Prospective Left Main Physiology RegistryPeter Kayaert, Mathieu Coeman, Chadi Ghafari, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Neuropharmacology|July 7, 2012
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism studyGeorg Winterer, Jürgen Gallinat, Jürgen Brinkmeyer, et al.
Physiological Reports|October 30, 2025
Pattern of extra-diaphragmatic respiratory muscle activity during exercise in patients with unilateral diaphragm dysfunctionAntenor Rodrigues, Zafeiris Louvaris, Sauwaluk Dacha, et al.
Acta Cardiologica|April 20, 2022
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational studyPhilippe van de Borne, André Peeters, Luc Janssens, et al.
Cardiology Research|August 10, 2023
A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V TrialAlexandre Abizaid, Ricardo Costa, Sasko Kedev, et al.
Journal of the American Heart Association|September 17, 2021
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS TrialPascal Vranckx, Marco Valgimigli, Ayodele Odutayo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
Journal of the American College of Cardiology|October 31, 2024
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA TrialRobert W Yeh, Olivier F Bertrand, Ehtisham Mahmud, et al.
American Heart Journal|January 12, 2020
Validation of the all-comers design: Results of the TARGET-AC substudyGabor G Toth, Alexandra Lansky, Andreas Baumbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
The Journal of Invasive Cardiology|May 23, 2023
iFR/FFR/IVUS Discordance and Clinical Implications: Results From the Prospective Left Main Physiology RegistryPeter Kayaert, Mathieu Coeman, Chadi Ghafari, et al.
Pageof 12